Omar Albanyan

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 4

Top Topics

Acute Myeloid Leukemia

Prognostic Factors

Hematopoietic Stem Cell

Top Venues

Therapeutic advances in hematology

Science advances

This page only lists publications with an associated author ORCID identifier.

Publications

Marion Subklewe, Ariel Perez, Gloria Iacoboni, Viktoria Blumenberg, Veit L Bücklein, Simon Völkl, Olaf Penack, Omar Albanyan, Sophia Stock, Fabian Müller, Philipp Karschnia, Agnese Petrera, Kayla M Reid, Rawan G Faramand, Marco L Davila, Karnav Modi, Erin A Dean, Christina A Bachmeier, Michael von Bergwelt-Baildon, Frederick L Locke, Wolfgang Andreas Bethge, Lars Bullinger, Andreas Mackensen, Pere Barba, Michael D Jain, Marion Subklewe
Severe hematotoxicity after CD19 CAR-T therapy is associated with suppressive immune dysregulation and limited CAR-T expansion. Science advances 9 (38) (2023)
Omar Albanyan, Julio C Chavez, Javier Munoz
The role of CAR-T cell therapy as second line in diffuse large B-cell lymphoma. Therapeutic advances in hematology 13 (2022)
Sylvia L Crowder, Rachel Sauls, Laura Redwine, Michael Nieder, Omar Albanyan, Hassaan Yasin, Farhad Khimani, Marilyn Stern
Mindfulness in Adolescent and Young Adult (AYA) Patients Undergoing Hematopoietic Stem Cell Transplantation (HSCT): A Qualitative Study. Cancers 14 (11) (2022)
Omar Albanyan, Julio C Chavez, Javier Munoz
The role of CAR-T cell therapy as second line in diffuse large B-cell lymphoma. Therapeutic advances in hematology 13 (2022)